Treat-to-Target or High-Intensity Statin in Patients With Coronary Artery Disease: A Randomized Clinical Trial.

Author: , AhnChul-Min, ChoiDonghoon, HongBum-Kee, HongMyeong-Ki, HongSung-Jin, JangYangsoo, KangWoong Chol, KimByeong-Keuk, KimJung-Sun, KoYoung-Guk, LeeJin-Bae, LeeJong-Young, LeeSeung-Jun, LeeYong-Joon, YangTae-Hyun, YoonJunghan

Paper Details 
Original Abstract of the Article :
In patients with coronary artery disease, some guidelines recommend initial statin treatment with high-intensity statins to achieve at least a 50% reduction in low-density lipoprotein cholesterol (LDL-C). An alternative approach is to begin with moderate-intensity statins and titrate to a specific L...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989958/

データ提供:米国国立医学図書館(NLM)

Treat-to-Target vs. High-Intensity Statin: A Camel's Quest for Optimal Coronary Artery Disease Management

Coronary artery disease (CAD), a condition affecting the heart's blood vessels, is like a blockage in a vital desert trade route, hindering the flow of essential resources. This randomized clinical trial investigates two approaches to statin therapy for CAD: treat-to-target and high-intensity statin. The study aims to determine which approach is more effective in reducing LDL-C levels and improving overall cardiovascular health. The study is currently ongoing, and the results are eagerly awaited.

Navigating the Path to Optimal CAD Management: A Camel's Perspective

This research highlights the ongoing efforts to optimize CAD management, seeking to find the most effective and individualized treatment strategies. The quest for improved treatment approaches is like searching for a clearer path through a complex and challenging desert.

A Camel's Advice for Managing CAD

Managing CAD is a crucial aspect of cardiovascular health, akin to ensuring a smooth and reliable caravan route. Consulting with a healthcare professional to discuss treatment options and monitor progress is essential for optimal outcomes.

Dr.Camel's Conclusion

This clinical trial explores the optimal approach to statin therapy for CAD, a condition affecting millions worldwide. The study aims to determine the most effective strategy for reducing LDL-C levels and improving overall cardiovascular health. It's a reminder that the pursuit of better treatment options for chronic conditions is an ongoing journey, requiring persistent research and innovation.

Date :
  1. Date Completed 2023-04-06
  2. Date Revised 2023-09-07
Further Info :

Pubmed ID

36877807

DOI: Digital Object Identifier

PMC9989958

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.